OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Journal is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
PET Imaging of Metabolism, Perfusion, and Hypoxia	54
Social Drivers of Cancer Risk and Outcomes Among African American Men	43
Toxicities From Antibody-Drug Conjugates	34
Oncology Physician Workforce Diversity	19
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	18
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	18
Individualizing Therapy for Malignant Gliomas	17
Clinical Evidence Generation During a Pandemic	15
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	14
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	14
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go	14
Health Care Policy and Disparities in Health	14
Building a Bridge to Equity in Health and Health Care in Cancer Care	14
Stereotactic Body Radiation Therapy	13
Melanoma—Modern Treatment for Metastatic Melanoma	13
Nonoperative Management for Rectal Cancer	12
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies	11
Clinical Targeting of Altered Metabolism in High-Grade Glioma	11
The Principles and Practice of PARP Inhibitor Therapy	11
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	11
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	11
Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy	10
Metastatic Melanoma Treatment in Special Populations	9
Antibody Drug Conjugates in Multiple Myeloma	9
Primary Prevention of Cancer	9

Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	9
Germline Predisposition to Myelodysplastic Syndromes	8
Smoldering Myeloma Treatment	8
Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas	7
Diversity in Cancer Care	7
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	7
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	7
Prostate Cancer, Race, and Health Disparity	7
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	7
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	7
Rectal Cancer—The Only Constant Is Change	7
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	7
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	7
DNA Damage Repair Inhibitors—Combination Therapies	6
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	6
Supportive Care for Patients With Myelodysplastic Syndromes	6
Neurosurgical Advances for Malignant Gliomas	6
Role of the Microbiome in Immunotherapy of Melanoma	6
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	6
How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	6
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	6
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	6
Impact of Precision Medicine in Oncology	6
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	6
New Metabolomic Insights Into Cancer	6
Updates in the Management of Uveal Melanoma	6
Menopausal Hormone Therapy and Breast Cancer	6
How Far We’ve Come	6
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	6
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	6
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	5
Hormone Replacement Therapy After Breast Cancer	5
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	5
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	5
Discovery of Natural Products for Cancer Prevention	5
Estrogen for the Treatment and Prevention of Breast Cancer	5
Telehealth and Technology	5
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	5
Introduction	5
Telemedicine Across the Cancer Care Continuum	5
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	5